Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH NATCO PHARMA PROCTER & GAMBLE HEALTH/
NATCO PHARMA
 
P/E (TTM) x 34.5 13.3 258.4% View Chart
P/BV x 10.5 3.5 300.7% View Chart
Dividend Yield % 2.0 0.6 349.2%  

Financials

 PROCTER & GAMBLE HEALTH   NATCO PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
NATCO PHARMA
Mar-23
PROCTER & GAMBLE HEALTH/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs5,366847 633.7%   
Low Rs3,883502 773.5%   
Sales per share (Unadj.) Rs740.7148.4 499.3%  
Earnings per share (Unadj.) Rs138.239.2 352.6%  
Cash flow per share (Unadj.) Rs155.248.2 322.1%  
Dividends per share (Unadj.) Rs95.005.50 1,727.3%  
Avg Dividend yield %2.10.8 251.9%  
Book value per share (Unadj.) Rs447.6267.1 167.6%  
Shares outstanding (eoy) m16.60182.47 9.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.24.5 137.3%   
Avg P/E ratio x33.517.2 194.5%  
P/CF ratio (eoy) x29.814.0 212.9%  
Price / Book Value ratio x10.32.5 409.2%  
Dividend payout %68.714.0 489.8%   
Avg Mkt Cap Rs m76,761123,049 62.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0624,867 42.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,29627,071 45.4%  
Other income Rs m1841,285 14.3%   
Total revenues Rs m12,48028,356 44.0%   
Gross profit Rs m3,2479,117 35.6%  
Depreciation Rs m2811,638 17.2%   
Interest Rs m8145 5.3%   
Profit before tax Rs m3,1428,619 36.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8471,466 57.8%   
Profit after tax Rs m2,2957,153 32.1%  
Gross profit margin %26.433.7 78.4%  
Effective tax rate %27.017.0 158.5%   
Net profit margin %18.726.4 70.6%  
BALANCE SHEET DATA
Current assets Rs m11,71330,003 39.0%   
Current liabilities Rs m6,7916,831 99.4%   
Net working cap to sales %40.085.6 46.8%  
Current ratio x1.74.4 39.3%  
Inventory Days Days26363 413.9%  
Debtors Days Days343115 297.6%  
Net fixed assets Rs m10,61726,571 40.0%   
Share capital Rs m166365 45.5%   
"Free" reserves Rs m7,26548,373 15.0%   
Net worth Rs m7,43148,738 15.2%   
Long term debt Rs m00-   
Total assets Rs m22,33056,574 39.5%  
Interest coverage x409.160.4 676.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 115.1%   
Return on assets %10.312.9 79.9%  
Return on equity %30.914.7 210.4%  
Return on capital %42.418.0 235.7%  
Exports to sales %00-   
Imports to sales %13.110.2 127.5%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,6052,772 57.9%   
Fx inflow Rs m1,46517,256 8.5%   
Fx outflow Rs m1,6052,772 57.9%   
Net fx Rs m-14014,484 -1.0%   
CASH FLOW
From Operations Rs m2,3608,491 27.8%  
From Investments Rs m-215-4,771 4.5%  
From Financial Activity Rs m-985-3,630 27.1%  
Net Cashflow Rs m1,160208 557.8%  

Share Holding

Indian Promoters % 0.0 49.7 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 25.0 81.1%  
FIIs % 7.6 13.7 55.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 50.3 95.8%  
Shareholders   56,730 207,571 27.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Natco Pharma Share Price Performance

Period Procter & Gamble Health Natco Pharma S&P BSE HEALTHCARE
1-Day -0.55% -2.11% 1.18%
1-Month -7.47% -3.19% -0.75%
1-Year -3.02% 72.80% 61.82%
3-Year CAGR -9.12% 4.96% 18.16%
5-Year CAGR 5.75% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.